In the current scenario, prolonged consumption of alcohol across the globe is upsurging an
appreciable number of patients with the risk of alcohol-associated liver diseases. According …

Objective Alcoholic liver disease (ALD) is a liver damage disease caused by long-term
heavy drinking. Currently, there is no targeted pharmaceutical intervention available for the …

1-O-Acetylbritannilactone (ABL) is a marker component of Inula britannica L. and is reported
to exhibit multiple pharmacological activities, including antiaging, anti-inflammatory, and …

Objective Employing network pharmacology and molecular docking, the study predicts the
active compounds in garlic and elucidates their mechanism in inhibiting the development of …

The rate of alcohol consumption and prevalence of alcohol use disorder (AUD) is on the
rise. In fact, 1 in 12 adults in the United States report heavy alcohol consumption, which is …

The coronavirus disease-2019 (COVID-19) pandemic has had a large impact on patients
with chronic liver disease (CLD) and liver transplantation (LT) recipients. Patients with …

Alcohol-related liver disease is a spectrum of disease in which continued, significant alcohol
use can cause progression from fatty changes in the liver to inflammation, fibrosis, and …

Alcohol consumption induces hepatocyte damage through complex processes involving
oxidative stress and disrupted metabolism. These factors alter proteomic and epigenetic …

In this editorial, we examine a paper by Koizumi et al, on the role of peroxisome proliferator-
activated receptor (PPAR) agonists in alcoholic liver disease (ALD). The study determined …

Methods: We pooled individual-level data from 12 studies from the United States, Russia,
Uganda, and South Africa with PEth, AUDIT-C (Alcohol Use Disorders Identification Test …